The release is transparent about potential conflicts of interest and provides a good snapshot of the benefits. The release would have been better if it dialed back on the sensational language and included the cost of this pricey drug.
This release would have been more complete with a few more details and disclosure of a long-standing financial relationship between author and sponsor.
This release on a small study does not provide enough data to show that the three-pronged treatment studied can “cure” prostate cancer.
There are lessons to be learned from this small study. We wish the release had included more numbers and caveats from the published article.
The addition of cost and the degree of improvement for this alternative treatment for hip pain would have made this release more complete.
The release also neglects to cover cost and any measurable benefits associated with the procedure.
Sensational terms like “revolutionized” are inapplicable when used to describe a new treatment that has yet to be tested on humans.
This summary of pet ownership and allergies is mostly cautious about the observational research but more details on the study itself are needed.